PCSK9 Inhibition Attenuates Alcohol-Associated Neuronal Oxidative Stress and Neuroinflammation

被引：0
|
作者：
Wagner, Josephin [1 ]
Park, Lauren [1 ]
Mukhopadhyay, Partha [1 ]
Jung, Jeesun [1 ]
Hamandi, Ali [1 ]
Pacher, Pal [1 ]
Lohoff, Falk [1 ]
机构：
[1] NIAAA, NIH, Bethesda, MD USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷
关键词：
Alcohol Use Disorder - Treatment; Oxidative Stress; Neuroinflammation; Monoclonal Antibodies;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P608
引用
收藏
页码：414 / 414
页数：1
相关论文
共 50 条
  • [1] PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury
    Wagner, Josephin
    Park, Lauren M.
    Mukhopadhyay, Partha
    Matyas, Csaba
    Trojnar, Eszter
    Damadzic, Ruslan
    Jung, Jeesun
    Bell, Andrew S.
    Mavromatis, Lucas A.
    Hamandi, Ali M.
    Rosoff, Daniel B.
    Vendruscolo, Leandro F.
    Koob, George F.
    Pacher, Pal
    Lohoff, Falk W.
    BRAIN BEHAVIOR AND IMMUNITY, 2024, 119 : 494 - 506
  • [2] PCSK9 inhibition attenuates neuroinflammation and oxidative stress in a rat model of chronic alcohol exposure
    Wagner, J.
    Mukhopadhyay, P.
    Park, L.
    Bell, A.
    Mavromatis, L.
    Hamandi, A.
    Damadzic, R.
    Pacher, P.
    Lohoff, F. W.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 256 - 256
  • [3] PCSK9 Inhibition via Alirocumab Attenuates Neuroinflammation in a Rat Model of Chronic Alcohol Consumption
    Wagner, Josephin
    Park, Lauren
    Damadzic, Ruslan
    Lee, Jisoo
    Lohoff, Falk
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S322 - S322
  • [4] THE PCSK9 INHIBITOR ALIROCUMAB ATTENUATES NEUROINFLAMMATION IN RATS CHRONICALLY EXPOSED TO ALCOHOL
    Wagner, J.
    Damadzic, R.
    Lee, J.
    Yoo, J.
    Lohoff, F. W.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 77A - 77A
  • [5] Targeting Oxidative Stress in Neurodegenerative Disorders: A Novel Role for PCSK9 Inhibition?
    Park, Lauren M.
    Pacher, Pal
    Lohoff, Falk W.
    ACS CHEMICAL NEUROSCIENCE, 2024, 15 (15): : 2662 - 2664
  • [6] Effects of PCSK9 Inhibition on Plasma PCSK9 Concentration and Hepatic PCSK9 Expression
    Shapiro, Michael D.
    Tavori, Hagai
    Oleaga, Carlota
    Miles, Joshua
    Fazio, Sergio
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [7] PCSK9 inhibition in PAD
    Huynh, Karina
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (01) : 4 - 5
  • [8] PCSK9 inhibition in PAD
    Karina Huynh
    Nature Reviews Cardiology, 2018, 15 : 4 - 5
  • [9] The promises of PCSK9 inhibition
    Petrides, Francine
    Shearston, Kate
    Chatelais, Mathias
    Guilbaud, Florian
    Meilhac, Olivier
    Lambert, Gilles
    CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (04) : 307 - 312
  • [10] Update on PCSK9 inhibition
    Katzmann, Julius L.
    Custodis, Florian
    Schirmer, Stephan H.
    Laufs, Ulrich
    HERZ, 2022, 47 (03) : 196 - 203
12345